These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 6306053)

  • 1. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.
    Sullivan JL; Byron KS; Brewster FE; Baker SM; Ochs HD
    J Clin Invest; 1983 Jun; 71(6):1765-78. PubMed ID: 6306053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked lymphoproliferative syndrome.
    Sullivan JL; Woda BA
    Immunodefic Rev; 1989; 1(4):325-47. PubMed ID: 2561059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
    Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
    Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient natural killer cell activity in x-linked lymphoproliferative syndrome.
    Sullivan JL; Byron KS; Brewster FE; Purtilo DT
    Science; 1980 Oct; 210(4469):543-5. PubMed ID: 6158759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathology of the X-linked lymphoproliferative syndrome.
    Purtilo DT
    Haematol Blood Transfus; 1981; 26():207-14. PubMed ID: 6274747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunodeficiency as a factor in lymphomagenesis.
    Purtilo DT; Sakamoto K
    Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory T cells in males vulnerable to Epstein-Barr virus with the X-linked lymphoproliferative syndrome.
    Lai PK; Yasuda N; Purtilo DT
    Am J Pediatr Hematol Oncol; 1987; 9(2):179-82. PubMed ID: 3035958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune deficiency in the X-linked lymphoproliferative syndrome. II. Immunoregulatory T cell defects.
    Lindsten T; Seeley JK; Ballow M; Sakamoto K; St Onge S; Yetz J; Aman P; Purtilo DT
    J Immunol; 1982 Dec; 129(6):2536-40. PubMed ID: 6292291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective control of Epstein-Barr virus-infected B cell growth in patients with X-linked lymphoproliferative disease.
    Yasuda N; Lai PK; Rogers J; Purtlo DT
    Clin Exp Immunol; 1991 Jan; 83(1):10-6. PubMed ID: 1846327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
    Kammermeier-Schmidt U; Weiss M; Belohradsky BH
    Monatsschr Kinderheilkd; 1993 Mar; 141(3):201-6. PubMed ID: 8386321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects.
    Harada S; Sakamoto K; Seeley JK; Lindsten T; Bechtold T; Yetz J; Rogers G; Pearson G; Purtilo DT
    J Immunol; 1982 Dec; 129(6):2532-5. PubMed ID: 6292290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.
    Grierson HL; Skare J; Hawk J; Pauza M; Purtilo DT
    Am J Med Genet; 1991 Sep; 40(3):294-7. PubMed ID: 1683154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma in a family with X-linked lymphoproliferative syndrome with acute Epstein-Barr virus infection.
    Okano M; Thiele GM; Kobayashi RH; Davis JR; Synovec MS; Grierson HL; Jaffe HS; Purtilo DT
    J Clin Immunol; 1989 Jan; 9(1):48-54. PubMed ID: 2539385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
    Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
    Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells.
    Nagy N; Mattsson K; Maeda A; Liu A; Székely L; Klein E
    Immunol Lett; 2002 Jun; 82(1-2):141-7. PubMed ID: 12008045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A boy with fatal infectious mononucleosis suspected as the first Japanese case of X-linked lymphoproliferative syndrome.
    Tsutsumi H; Kamazaki H; Satoh M; Imai S; Nakata S; Chiba S
    Scand J Infect Dis; 1998; 30(6):610-2. PubMed ID: 10225392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic infectious mononucleosis syndrome, pancytopenia, and polyclonal B-lymphoproliferation terminating in acute lymphoblastic leukemia.
    Finlay J; Luft B; Yousem S; Wood GS; Link M; Arvin A; Glader B; Lennette E; Shatsky M; Olds L
    Am J Pediatr Hematol Oncol; 1986; 8(1):18-27. PubMed ID: 3013037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK)-cell activity in the X-linked lymphoproliferative syndrome.
    Harada S; Bechtold T; Seeley JK; Purtilo DT
    Int J Cancer; 1982 Dec; 30(6):739-44. PubMed ID: 6298119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.